Results 221 to 230 of about 290,304 (371)

Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment [PDF]

, 2017
A Rai, AG Tolcher, AX Zhu, Caio Max S Rocha-Lima, David Portnoy, DP Brooks, E Gabriela Chiorean, E Suzuki, J Albores-Saavedra, J Nelson, J Valle, JE Rogers, JF Guion-Dussere, Jitendra Gandhi, L Goyal, M Yanagisawa, Manik Amin, NV Rajeshkumar, NV Rajeshkumar, P Papakostas, R Pazdur, Richard Kim, RK Jain, RL Siegel, S He, SC Lee, SY Oh, T Sasaki, T Walter, Tao Song, William P Harris   +30 more
core   +3 more sources

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

Journal of Clinical Oncology, 2010
D. Sargent, S. Marsoni, G. Monges, S. Thibodeau, R. Labianca, S. Hamilton, A. French, B. Kabat, N. Foster, V. Torri, C. Ribic, A. Grothey, M. Moore, A. Zaniboni, J. Seitz, F. Sinicrope, S. Gallinger   +16 more
semanticscholar   +1 more source

Should Induction Chemotherapy Be Considered First‐Line Therapy for Sinonasal Undifferentiated Carcinoma?

The Laryngoscope, EarlyView.
Daniel X. Ma, Shirley Y. Su, Bobby A. Tajudeen, Edward C. Kuan   +3 more
wiley   +1 more source

Biomarker‐based long‐term safety and efficacy of PD‐1/PD‐L1 inhibitors combined with chemotherapy in advanced gastroesophageal carcinomas: A systematic review and meta‐analysis

Precision Medical Sciences, EarlyView.
This graphical abstract concisely encapsulates the principal findings of the meta‐analysis, emphasizing the notable survival advantages of PD‐1/PD‐L1 inhibitors in conjunction with chemotherapy for advanced gastroesophageal tumors. The visual presentation briefly defines the study's history, methodologies, results, and conclusions, while highlighting ...
Muhammad Ahsan, Muhammad Javaid Umer, Rath Shree, Jan Qureshi Ahmar, Ahmad Khan Mudassir, Masood Salman, Muhammad Hassan, Hayyat Omna, Iqbal Javed, Asraf Hussain   +9 more
wiley   +1 more source

Silent toxicity: A rare case of 5-fluorouracil-induced hyperammonemic encephalopathy. [PDF]

Oncoscience
Kalfoutzou A, Rapti C, Bagiokou E, Kolintzikis V, Ramfidis V.   +4 more
europepmc   +1 more source

SNPs and blood inflammatory marker featured machine learning for predicting the efficacy of fluorouracil-based chemotherapy in colorectal cancer [PDF]

Jiyifan Li, Wenxin Zhang, Lü Chen, Xiang Mao, Xinhai Wang, Jiafeng Liu, Yuxin Huang, Huijie Qi, Li Chen, Huanying Shi, Bicui Chen, Mingkang Zhong, Qunyi Li, Tianxiao Wang   +13 more
openalex   +1 more source

Nanoparticle polymeric micellar paclitaxel compared with paclitaxel for advanced esophageal squamous cell carcinoma

Precision Medical Sciences, EarlyView.
The nanoparticle polymeric micellar paclitaxel plus nedaplatin regimen demonstrates superior efficacy and tolerable toxicities compared to the paclitaxel–nedaplatin combination as a first‐line treatment for advanced esophageal squamous cell carcinoma.
Yu‐Qing Cao, Meng Song, Bing‐jie Xue, Fei‐Yu Wang, Xiang‐Ming Huang, Jie Cao, Ai‐Guo Cao, Xin‐En Huang   +7 more
wiley   +1 more source

A case of folinic acid, fluorouracil and oxaliplatin (FOLFOX) chemotherapy regimen associated neurotoxicity and review of literature. [PDF]

BMC Neurol
Srivastava J, DO EK, Sivakumar S, Mullaguri N.   +3 more
europepmc   +1 more source

Controlled release of 5-fluorouracil from microporous zeolites [PDF]

, 2014
Bouropoulos, Nikolaos, Cox, Paul A., Ewart, Sinead, Fatouros, Dimitrios G., Kachrimanis, Kyriakos, Moschovi, Anastasia Maria, Nikolakis, Vladimiros, Niopas, Ioannis, Siokou, Angeliki, Spanakis, Marios, Sygellou, Lamprini, Theodoropoulos, Dimitrios, Vizirianakis, Ioannis S.   +12 more
core   +1 more source

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

New England Journal of Medicine, 2007
J. Vermorken, É. Remenár, C. V. van Herpen, T. Gorlia, R. Mesía, M. Degardin, J. Stewart, S. Jelić, J. Betka, J. Preiss, D. van den Weyngaert, A. Awada, D. Cupissol, H. Kienzer, A. Rey, Isabelle Desaunois, J. Bernier, J. Lefebvre   +17 more
semanticscholar   +1 more source